retinal disease
Information
- Disease name
- retinal disease
- Disease ID
- DOID:5679
- Description
- "An eye disease that is located_in the retina." [url:http\://en.wikipedia.org/wiki/Retina#Diseases_and_disorders]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04636307 | Active, not recruiting | Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART) | September 22, 2021 | March 22, 2025 | |
| NCT03846193 | Active, not recruiting | Phase 1/Phase 2 | FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD | December 17, 2018 | June 28, 2024 |
| NCT05158296 | Active, not recruiting | Phase 2/Phase 3 | Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) | December 8, 2021 | December 2024 |
| NCT04123626 | Active, not recruiting | Phase 1/Phase 2 | A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene | October 7, 2019 | June 7, 2022 |
| NCT04661124 | Active, not recruiting | Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position | December 10, 2020 | April 2024 | |
| NCT03894020 | Active, not recruiting | GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) | January 8, 2019 | March 2, 2024 | |
| NCT03872479 | Active, not recruiting | Phase 1/Phase 2 | Single Ascending Dose Study in Participants With LCA10 | September 26, 2019 | May 23, 2025 |
| NCT03913143 | Active, not recruiting | Phase 2/Phase 3 | A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) | April 4, 2019 | March 2023 |
| NCT00792259 | Completed | Topcon 3D OCT-1000 Optical Coherence Tomography System | October 2008 | November 2008 | |
| NCT00837252 | Completed | Phase 1/Phase 2 | Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy | February 2009 | April 2010 |
| NCT01100307 | Completed | Phase 3 | A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema | May 2010 | August 2012 |
| NCT00001733 | Completed | Screening for Studies on Retinovascular Diseases | March 6, 1998 | July 2, 2008 | |
| NCT01227993 | Completed | Phase 1/Phase 2 | Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy | October 2010 | June 2013 |
| NCT01384487 | Completed | Nidek RS3000 Comparative Study | June 2011 | November 2011 | |
| NCT00001865 | Completed | Phase 2 | HAT in Eye Complications of Behcet's Disease | July 1999 | June 2004 |
| NCT01468337 | Completed | Phase 1/Phase 2 | Topical Interferon Gamma-1b for Central Serous Chorioretinopathy | October 2011 | February 2014 |
| NCT01482195 | Completed | Phase 1 | Trial of Subretinal Injection of (rAAV2-VMD2-hMERTK) | August 2011 | August 2019 |
| NCT00005784 | Completed | Evaluation and Treatment of Patients With Retinal Disease | May 31, 2000 | August 8, 2008 | |
| NCT01878032 | Completed | Color Vision as a Measure for Inherited Retinal Diseases | June 3, 2013 | April 14, 2017 | |
| NCT02050880 | Completed | OCT Agreement and Crossed Precision Study | January 2014 | June 2014 | |
| NCT02162953 | Completed | Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases. | February 2014 | December 31, 2022 | |
| NCT02315170 | Completed | N/A | Assessment of Novel Intraocular Injection Guide | September 2014 | January 2015 |
| NCT06173414 | Completed | Adaptive Optics ScanningLaser Ophthalmoscope Safety and Efficacy Clinical Trial | July 5, 2023 | November 16, 2023 | |
| NCT02811536 | Completed | Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A) | February 13, 2017 | November 25, 2022 | |
| NCT02822612 | Completed | The EASE Study - Human Factor and Usability Testing of a Binocular OCT System | May 2016 | October 2016 | |
| NCT00006188 | Completed | Evaluation and Treatment of Patients With Inflammatory Eye Diseases | August 19, 2000 | July 25, 2008 | |
| NCT03148132 | Completed | Phase 4 | VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP | May 23, 2017 | August 30, 2018 |
| NCT03396042 | Completed | Natural History Study of CEP290-Related Retinal Degeneration | December 17, 2017 | May 6, 2022 | |
| NCT05664555 | Completed | Phase 4 | Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study) | February 1, 2023 | March 31, 2024 |
| NCT03505567 | Completed | N/A | Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100 | April 21, 2018 | September 1, 2018 |
| NCT05416268 | Completed | N/A | Study to Compare the Diopsys NOVA and LKC RETeval Devices | May 4, 2022 | May 6, 2022 |
| NCT04912622 | Completed | N/A | RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders | May 19, 2021 | October 31, 2022 |
| NCT03712670 | Completed | N/A | Nutraceutical Support With Omega-3 | January 1, 2016 | March 15, 2017 |
| NCT00035906 | Completed | Phase 2 | Research Study in Patients With Persistent Macular Edema | October 2001 | August 2004 |
| NCT03780257 | Completed | Phase 1/Phase 2 | Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene | March 6, 2019 | October 14, 2021 |
| NCT04891211 | Completed | N/A | Retinal Changes in Vitamin D Deficiency | February 12, 2021 | March 10, 2021 |
| NCT04398394 | Completed | N/A | Retinal Imaging With Oblique Illumination | August 11, 2020 | April 28, 2022 |
| NCT04125043 | Completed | Accuracy of the Red Reflex Test in the Pediatric Population | March 1, 2020 | August 1, 2023 | |
| NCT04318132 | Completed | N/A | Agreement and Precision Study of the Nidek Mirante | January 25, 2020 | December 30, 2021 |
| NCT04137120 | Completed | Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice | February 19, 2021 | February 1, 2023 | |
| NCT04233619 | Completed | Correlation of Microvascular Ophthalmic Disease With Macrovascular Coronary Artery Disease in Trinidad | May 1, 2019 | April 15, 2021 | |
| NCT04246866 | Completed | Phase 1 | First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration | December 19, 2019 | October 21, 2020 |
| NCT00069199 | Completed | Optical Coherence Tomography Comparative Study | September 2003 | August 2005 | |
| NCT00370851 | Completed | Phase 3 | Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial | August 2006 | June 2008 |
| NCT03824782 | Completed | N/A | The Effect of Eyemasks on Neonatal Stress Following Dilated Retinal Examination | April 1, 2016 | June 30, 2017 |
| NCT03868462 | Completed | N/A | Optos P200TE Agreement and Precision Study | February 11, 2019 | September 16, 2019 |
| NCT03902925 | Completed | Phase 1/Phase 2 | Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia | January 1, 2019 | October 31, 2019 |
| NCT04003831 | Completed | N/A | Navigated OCT Imaging With the P200TxE | June 13, 2019 | January 18, 2021 |
| NCT03076697 | Enrolling by invitation | Smartphone Screening for Eye Diseases | April 16, 2015 | August 30, 2028 | |
| NCT05921162 | Enrolling by invitation | A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection | July 14, 2023 | December 2024 | |
| NCT06455826 | Not yet recruiting | Phase 1 | MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) | June 2024 | November 2025 |
| NCT06455384 | Not yet recruiting | N/A | The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services | July 1, 2024 | July 1, 2026 |
| NCT06451068 | Not yet recruiting | N/A | Peripheral Retina Robotically Aligned OCT Study | September 2024 | January 2025 |
| NCT05819307 | Not yet recruiting | Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI) | May 1, 2023 | May 1, 2024 | |
| NCT06380075 | Not yet recruiting | N/A | COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease | June 2024 | May 2025 |
| NCT02435940 | Recruiting | Inherited Retinal Degenerative Disease Registry | June 2014 | June 2037 | |
| NCT01145196 | Recruiting | Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene | August 23, 2010 | ||
| NCT01432847 | Recruiting | Cell Collection to Study Eye Diseases | September 7, 2011 | ||
| NCT01496625 | Recruiting | National Eye Institute Biorepository for Retinal Diseases | June 18, 2012 | ||
| NCT03011541 | Recruiting | N/A | Stem Cell Ophthalmology Treatment Study II | January 2016 | July 31, 2026 |
| NCT03713268 | Recruiting | Intraoperative OCT Guidance of Intraocular Surgery II | September 30, 2018 | May 31, 2025 | |
| NCT04935749 | Recruiting | Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs | July 1, 2021 | April 1, 2026 | |
| NCT04956237 | Recruiting | Retinal Surgery With or Without Anesthesiologist, Comparison of Surgeon and Patient's Comfort | September 9, 2021 | March 2023 | |
| NCT05130385 | Recruiting | High Resolution Optical Coherence Tomography | November 30, 2021 | November 30, 2023 | |
| NCT05323032 | Recruiting | N/A | Multifocal Electroretinogram in Normal Egyptian Population | March 22, 2022 | December 30, 2022 |
| NCT05447845 | Recruiting | Rapid Computerized Visual Acuity Test | January 1, 2019 | December 31, 2022 | |
| NCT05623293 | Recruiting | Ophthalmologic Outcomes in Patients With Carotid Artery Stenosis | January 1, 2022 | December 31, 2023 | |
| NCT05699096 | Recruiting | Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly | July 1, 2023 | July 1, 2026 | |
| NCT05747430 | Recruiting | Phase 2 | SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF) | February 22, 2023 | August 30, 2024 |
| NCT05750589 | Recruiting | Phase 3 | Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections | February 22, 2023 | August 30, 2024 |
| NCT05797896 | Recruiting | Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study | February 7, 2023 | December 31, 2026 | |
| NCT05958927 | Recruiting | Fundus Findings and Thiol-Disulfide Homeostais | April 13, 2023 | November 2023 | |
| NCT06011798 | Recruiting | Phase 2 | Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE) | August 23, 2023 | June 2025 |
| NCT06074731 | Recruiting | Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography | June 1, 2017 | December 2026 | |
| NCT06139523 | Recruiting | Optimize Pediatric OCT Imaging | January 24, 2024 | December 2025 | |
| NCT06269666 | Recruiting | N/A | P200TxE Diseased Eye Image Collection | January 31, 2024 | June 30, 2024 |
| NCT06287645 | Recruiting | Color Fundus Photograph With Experts Labelling | May 12, 2022 | June 30, 2026 | |
| NCT06289452 | Recruiting | Early Phase 1 | Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis | March 8, 2024 | December 31, 2029 |
| NCT06305416 | Recruiting | Phase 3 | A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema | March 30, 2024 | April 2025 |
| NCT06394232 | Recruiting | Phase 1/Phase 2 | Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. | June 4, 2024 | December 2030 |
| NCT04684394 | Terminated | Phase 2 | A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration | December 29, 2020 | February 18, 2022 |
| NCT00278486 | Terminated | Phase 1 | Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON) | August 2004 | April 2012 |
| NCT04110015 | Terminated | Assessment of Visual Function in Ophthalmic Disorders Using Virtual Visual Field Analysis | October 1, 2020 | August 23, 2021 | |
| NCT05176717 | Terminated | Phase 2/Phase 3 | Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) | December 15, 2021 | August 2, 2022 |
| NCT01585441 | Terminated | Phase 2 | Finasteride for Chronic Central Serous Chorioretinopathy | April 2012 | December 2013 |
| NCT03913130 | Terminated | Phase 1/Phase 2 | Extension Study to Study PQ-110-001 (NCT03140969) | May 13, 2019 | October 3, 2022 |
| NCT00001310 | Terminated | Tissue Studies of Human Eye Diseases | March 5, 1992 | September 16, 2015 | |
| NCT04643886 | Terminated | Phase 2 | A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration | July 30, 2020 | March 21, 2022 |
| NCT05615896 | Terminated | N/A | Data Collection With the P200TE and P200TxE | April 22, 2021 | June 17, 2022 |
| NCT03592017 | Unknown status | N/A | Performance of Long-wavelength Autofluorescence Imaging | October 1, 2018 | July 30, 2022 |
| NCT05158699 | Unknown status | Phase 3 | Effectiveness of Periocular Drug Injection in CATaract Surgery | October 13, 2021 | April 1, 2024 |
| NCT03586193 | Unknown status | Pars Plana Vitrectomy Alone in the Treatment of Macular Schisis in High Myopic Eyes | May 1, 2018 | May 31, 2019 | |
| NCT01920867 | Unknown status | N/A | Stem Cell Ophthalmology Treatment Study | August 2012 | July 2020 |
| NCT03422965 | Unknown status | N/A | Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus | May 8, 2017 | May 31, 2021 |
| NCT04255732 | Unknown status | N/A | Comparison of Wide-field Retinal Imaging | August 7, 2020 | October 2020 |
| NCT04130841 | Unknown status | N/A | Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery | September 30, 2019 | December 31, 2021 |
| NCT03823092 | Unknown status | Polarization Perception in Health and Disease. Testing a New Sight Test | November 9, 2017 | July 2019 | |
| NCT04855045 | Unknown status | Phase 2/Phase 3 | An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. | March 23, 2021 | December 2023 |
| NCT03786146 | Unknown status | Changes in Retinal Nerve Fiber Layer Thickness Detected by OCT in Diabetic Retinopathy After Panretinal Photocoagulation | January 1, 2019 | December 2019 | |
| NCT01024361 | Unknown status | Phase 4 | Cpap at Delivery Room for Preterm Infants | January 2009 | December 2010 |
| NCT02921568 | Unknown status | N/A | Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes | September 2016 | |
| NCT05334875 | Unknown status | N/A | Repeatability of Electroretinogram and Visual Evoked Potential | April 1, 2022 | October 30, 2022 |
| NCT03603990 | Withdrawn | N/A | Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema | September 1, 2018 | March 1, 2020 |
| NCT02445001 | Withdrawn | N/A | Erythrocyte Ghost Mediated Retinal Diagnosis | October 2013 | January 2016 |
- Disase is a (Disease Ontology)
- DOID:5614
- Cross Reference ID (Disease Ontology)
- ICD10CM:H35.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:362.9
- Cross Reference ID (Disease Ontology)
- MESH:D012164
- Cross Reference ID (Disease Ontology)
- NCI:C26875
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:29555009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0035309